Notoginsenoside Ft1

CAS No. 155683-00-4

Notoginsenoside Ft1( —— )

Catalog No. M20544 CAS No. 155683-00-4

Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 In Stock
10MG 77 In Stock
25MG 126 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Notoginsenoside Ft1
  • Note
    Research use only, not for human use.
  • Brief Description
    Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities.
  • Description
    Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    155683-00-4
  • Formula Weight
    917.13
  • Molecular Formula
    C47H80O17
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:6.67 mg/mL (7.27 mM)
  • SMILES
    CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4OC4OCC(O)C(O)C4O)C(C)(C)C3CCC21C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shen K Ji L Gong C et al. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways[J]. Biochemical Pharmacology 2012 84(6).
molnova catalog
related products
  • Ro 31-8220 Mesylate

    Ro 31-8220 is a pan-PKC inhibitor for PKC-α/βI/βII/γ/ε (IC50: 5/24/14/27/24 nM), and also shows potent inhibition against MSK1, MAPKAP-K1b, S6K1, and GSK3β.

  • (D-Pro2)-β-Casomorph...

    (D-Pro2)-β-Casomorphin (1-5) (bovine)

  • Sari 59-801

    Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).